CSIMarket
 
Sio Gene Therapies Inc.  (SIOX)
Other Ticker:  
 
 


The ascending corporation from the Major Pharmaceutical Preparations sector the SIOX published the fiscal span ending fourth quarter of 2022, results

Sio Gene Therapies Inc. recorded fourth quarter of 2022 operating deficit of $-13.037 millions

Published 2022-06-15T09:23:14-04:00
Goran Soko / CSIMarket.com Contributer

pills_rapid_release_pills_By_Katy_Warner_from_Orlando_FL_USA_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons The investors haven't anticipated any adjustments at the business throughout the the January to March 31 2022 reporting cycle at the company. Yet, they pay close attention to SIOXs' operating deficit which was at $-13.037 millions, during the matching time.

The smartest effort to frame the fiscal span ending fourth quarter of 2022 development, in the current instance of the business. Now, it's simple to measure the operating deficit of the fourth quarter of 2021, as it was $-3.239 millions.


Not alarmingly the small business realized a net loss of $-13.324 millions, that has widen from $-3.331 millions, in fourth quarter of 2021.

Sio Gene Therapies Inc. announced loss of $-71.89 millions and Revenues of $0.00 millions in the financial period 2022.

Net loss per share has widen to $-0.98 from $-0.62 in preceding financial year, while by 0 % from $0.00 millions a year prior.

Sio Gene Therapies Inc. is expected to report next financial results on August 11, 2022.


    Recently Reported Results
pills_blue_By_Tom_Varco_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons Global Blood Therapeutics Inc.

Compelling period by the company amid the financial span closing Jun 30 2022

For the most recent fiscal period company Deficit has swelled of $-1.26 per share compare to $-1.12 a year prior and from $-1.26 per share from the previous reporting season.

Revenues grew strongly by 50.457 % to $71.55 millions from $47.56 millions in the same reporting season a year prior and sequentially Revenues improved by 29.714 % from $55.16 millions.


factory_night_long_exposure_industry_power_industrial_energy_global-589754 Industrial production

The output of the nation's factories, mines and utilities declined


Dryvax_pd Pds Biotechnology Corp

Existing outlays were increasing at the PDSB in the second quarter of 2022

Following the bellwethers in the Major Pharmaceutical Preparations industry, a number of overlooked businesses are coming in with their earnings. PDSB said it has realized operating shortfall of $-7.092652 millions, for the second quarter of 2022.


coins-948603__340 Arya Sciences Acquisition Corp Iv

Working outlays have been building up at the ARYD in the second quarter of 2022 earnings season

As the April to June 30 2022 reporting cycle continues, many corporations have declared the results. Some of them, have been many constituents of the Blank Checks sector. As well as, now, ARYD reported operating loss of $-0.304811 millions, for the fiscal second quarter of 2022.


20_Dollar_bills3_Source_selbstfotografiert_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons Northrim Bancorp Inc.

Confronting the challenges, the the company over the April to June 30 2022 span

In the fiscal span ending June 30 2022 NRIM announced soft top and bottom-line, where net profit per share dropped by -37.59 % and revenue by -12.429 % year on year. Revenue were to $29.56 millions relative to $33.75 millions eps at $0.83 relative to $1.33 in the similar span a preceding year.


Warehouse_By Cayco_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Common Retail Inventories

March 2022 The inventories grew 2.9 %


workout_By_Nnu-12-22100541Tracy_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons Productivity

Productivity declined in first-quarter of 2022


Shopping_in_By_Ramunasjurevicius_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Common Personal Income and Spending

Consumer spending on the rise again in June 2022

Consumer dipped into their savings to ramp up spending in June 2022, as spending increase outpaced growth in disposable income, according to the latest government data.

ATM_nice_pd Community Trust Bancorp Inc

Top and Bottom-line went down at the company all along the April to June 30 2022 time-frame

For the second quarter of 2022 earnings season Community Trust Bancorp Inc income fell by -14.93 % of $1.14 per share compare to $1.34 a year ago and income improved by 2.7 % from $1.11 per share from the prior quarter.

Revenues decreased by -7.646 % to $55.21 millions from $59.79 millions in the same quarter a year ago and sequentially Revenues surged by 2.018 % from $54.12 millions.


By_NRMA_Motoring_and_Services_from_Sydney,_Australia__[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Common Kandi Technologies Group Inc.

Demanding quarter for the company in the second quarter of 2022

Weak demand caused growth in losses for the second quarter of 2022, KNDIs' net loss per share increased to $-0.02 from $0.54 where Revenue dropped by -30.241 % to $20.84 millions from $29.88 millions a year before.


customer_service_By_User_Mattes_(Own_work)__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Common Modivcare Inc.

Robust 32.873% Top-line rise at the company in the financial second quarter of 2022

company announced income per share of $0.24 and Revenue of $574.94 millions in the most recent fiscal period, MODVs' income per share dived $0.24 per share, versus $0.96 eps, earned in second quarter of 2021, although MODV saw its Revenue rise by 32.873 % in the similar period.


lab-217043__340 Pacific Biosciences Of California Inc.

Pacific Biosciences Of California Inc. reported noteworthy 15.867%, Revenues rise, all along the second quarter of 2022

For the second quarter of 2022 earnings season PACB Losses have swelled of $-0.32 per share compare to $-0.21 a year ago and EPS improved from $-0.37 per share from the prior financial reporting period.

Revenues inched up admirably by 15.867 % to $35.47 millions from $30.61 millions in the corresponding financial reporting period a year ago and sequentially Revenues surged by 6.915 % from $33.17 millions.


atm_citi_By_Magrealthkoo_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons.jpg Green Dot Corp

at the Green Dot Corp amid the most recent fiscal period

Lower orders led to vanishing revenues and an increased loss, in the most recent fiscal period GDOT reached zero gain to $0.00 per share, while Revenue dropped by -7.806 % to $362.77 millions, year on year.


Commercial_Street_By_Mtaylor848_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons Social Capital Hedosophia Holdings Corp. Vi

Working costs were increasing at the Social Capital Hedosophia Holdings Corp. Vi in the fiscal second quarter of 2022

The Blank Checks sector reporters continue to digest the second quarter of 2022 performance. Presently they observe operating loss of $-0.682275 millions, from the company, as it hasn't mentioned any revenue thus far, for the own April to June 30 2022 reporting season.




Other SIOX's Earnings Reports

Sio Gene Therapies reported first quarter 2022 earnings

Sio Gene Therapies reported third quarter 2021 earnings

Sio Gene Therapies reported second quarter 2021 earnings

       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

VRRM's Profile

Stock Price

VRRM's Financials

Business Description

Fundamentals

Charts & Quotes

VRRM's News

Suppliers

VRRM's Competitors

Customers & Markets

Economic Indicators

VRRM's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright Š 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071